These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5069316)

  • 1. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advantages and limitations of the galactosamine model].
    Decker K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():245-9. PubMed ID: 1029184
    [No Abstract]   [Full Text] [Related]  

  • 3. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of D-penicillamine on the galactosamine hepatitis model in the rat].
    Habersang S; Kozlik V; Leuschner F; von Schlichtegroll A
    Arzneimittelforschung; 1973 Jan; 23(1):56-7. PubMed ID: 4740696
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine.
    Andreicuţ S; Kerekes M
    Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in polyamine metabolism of rat liver after administration of D-galactosamine. Favorable effects of putrescine administration on galactosamine-induced hepatic injury.
    Daikuhara Y; Tamada F; Takigawa M; Takeda Y; Mori Y
    Gastroenterology; 1979 Jul; 77(1):123-32. PubMed ID: 447009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal experimental studies on the problem of liver damage by antitubercular agents (rifampicin and isoniazide) by means of the galactosamine model].
    Leinweber B; Mahrt R
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():300-3. PubMed ID: 1029192
    [No Abstract]   [Full Text] [Related]  

  • 8. [Galactosamine hepatitis: injury to the plasma membrane of hepatic cells following administration of D-galactosamine].
    Reutter W; Bachmann W
    Verh Dtsch Ges Inn Med; 1971; 77():1177-8. PubMed ID: 5155984
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of ubiquinone-10 on the development of D-galactosamine-induced hepatitis in rats].
    Sugrobova NP; Medvednik RS; Efimova LV; Katarzhnova TV; Liubarev AE; Shaposhnikov VM; Obol'nikova EA; Poznanskaia AA
    Biull Eksp Biol Med; 1992 Nov; 114(11):504-6. PubMed ID: 1290824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on d-galactosamine hepatitis after pretreatment with alpha-hexachlorocyclohexane.
    Schuchhardt C; Reutter W; Lesch R
    Beitr Pathol; 1976 Feb; 157(1):45-55. PubMed ID: 57771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation.
    Müller-Berghaus G; Reuter C; Bleyl U
    Am J Pathol; 1976 Feb; 82(2):393-406. PubMed ID: 1251892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the behavior of microsomal enzymes in the rat liver following galactosamine administration].
    Leber HW; Leinweber B; Platt D
    Verh Dtsch Ges Inn Med; 1971; 77():1179-82. PubMed ID: 4346176
    [No Abstract]   [Full Text] [Related]  

  • 16. Light and electron microscopic study of hermorrhagic hepatitis induced by trimethyllysine and D-galactosamine.
    Tompa A; Lapis K; Szende B
    Exp Pathol (Jena); 1977; 13(2-3):118-29. PubMed ID: 913531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 18. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine.
    Perings E; Brunner G; Vido I; Söling HD; Creutzfeldt W
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):130-4. PubMed ID: 4148023
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced D-galactosamine hepatotoxicity after propylthiouracil treatment in the rat.
    Mihas TA; Ceballos R; Hirschowitz BI; Gibson RG; Mihas AA
    J Med; 1982; 13(1-2):71-9. PubMed ID: 6956652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.